A. Wang - Concepedia

Author

A. Wang

Amgen (United States)

Also Known As

A Wang, A. Wang

Publications

781

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)New Mexico Clinical Research & Osteoporosis Center University Hospital of Geneva University of Liège University of British Columbia

About

A. Wang is an author at Amgen (United States) specializing in osteoporosis, women's health, and rheumatoid arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	42
2	Obstetrics	1	1	42
3	Menopause	1	1	42
4	Women's Health	1	1	42
5	Bone Health	1	1	42

A. Wang

Publications

756

Citations

H-Index

Page 1

	Year	Citations
Observations following discontinuation of long-term denosumab therapy Michael R. McClung, R.B. Wagman, Paul D. Miller, Osteoporosis International	2017	213
Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk Steven Boonen, Jonathan D. Adachi, Z. Man, The Journal of Clinical Endocrinology & Metabolism	2011	212
Relationship Between Bone Mineral Density <i>T</i>-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment Serge Ferrari, Cesar Libanati, Celia J. F. Lin, Journal of Bone and Mineral Research	2019	104
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years Serge Ferrari, Jonathan D. Adachi, Kurt Lippuner, Osteoporosis International	2015	76
Reduction in catheter-associated urinary tract infections by bundling interventions Karen Clarke, David Tong, Yi Pan, International Journal for Quality in Health Care	2012	62
Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis Michael R. McClung, Kurt Lippuner, Maria Luisa Brandi, Osteoporosis International Trabecular Bone ScoreBone DiseaseBone HealthGynecologyMenopause	2017	42
Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis Santiago Palacios, L. Kalouche-Khalil, René Rizzoli, Climacteric	2015	25
The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies David L. Kendler, Arkadi Chines, Maria Luisa Brandi, Osteoporosis International	2018	22

Page 1